Intensive Therapy Archival Research

Trauma, Psychological Clinical Trial

Official title:

Intensive Therapy Archival Research

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03271398
• Other study ID #: 2017-1001
• Status: Recruiting
• Phase: N/A
• First received: August 31, 2017
• Last updated: September 4, 2017
• Start date: August 2, 2017
• Est. completion date: December 31, 2022

Study information

• Verified date: September 2017
• Source: Trauma Institute & Child Trauma Institute
• Contact: Ricky Greenwald, PsyD
• Phone: 413-774-2340
• Email: cti[@]childtrauma.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This is an internal treatment evaluation to determine whether eye movement desensitization and reprocessing (EMDR) or progressive counting (PC) should become the preferred trauma treatment for the investigator's clients. The investigator is using routine/existing in-house measures and case files to track symptom reduction, trauma treatment time, rate of treatment switching (from EMDR to PC or vice versa), and rate of trauma treatment refusal. This is retrospective as well as prospective archival research.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1200
• Est. completion date: December 31, 2022
• Est. primary completion date: December 31, 2022
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Victims of crimes, including assault, rape, robbery, intimate partner violence, child abuse, kidnapping, vehicular homicide, and suicide

• Witnesses and family members of victims

Related Conditions & MeSH terms

• Psychological Trauma
• Trauma, Psychological

Intervention

Behavioral:
• EMDR
Eye movement desensitization and reprocessing (intensive format)
• PC
Progressive counting (intensive format)

Locations

Country	Name	City	State
United States	Trauma Institute & Child Trauma Institute	Northampton	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Trauma Institute & Child Trauma Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in TSI-2 following treatment	Trauma Symptom Inventory-2	Administered pre-treatment, two weeks post-treatment, and 12 weeks post-treatment
Primary	Change in TSCC following treatment	Trauma Symptom Checklist for Children	Administered pre-treatment, two weeks post-treatment, and 12 weeks post-treatment
Primary	Change in PRS following treatment	Problem Rating Scale	Administered pre-treatment, two weeks post-treatment, and 12 weeks post-treatment